Characterizing drug-tolerant persister cells in relapsed high grade neuroendocrine carcinomas
Carl M. Gay, MD, PhD
Finished Projects
Comprehensive molecular characterization of lung supra-carcinoids
Lynnette Fernandez-Cuesta, PhD
Deciphering and Potentiating Intrinsic Radiosensitivity of Pancreatic Neuroendocrine Tumors
Xavier M. Keutgen, MD
Defining Distinct Subtypes of NECs to Predict Therapeutic Vulnerabilities
Carl Gay, MD, PhD
Defining the immune landscape of NETs – towards rational combination therapy
Tim Meyer, MD, PhD
Defining the immune landscape of neuroendocrine tumors in response to conventional treatment – towards rational combination therapy
Tim Meyer, MD, PhD
Determining whether there are unique protein expression patterns in gastrointestinal NETs
Daniel Chung, MD
Developing novel treatments for NETs using CAR T-Cell Technology
Carl June, MD; Xianxin Hua, MD, PhD; David Metz, MD
Development of ex-vivo models of metastatic neuroendocrine tumors
Raj Srirajaskanthan, PhD
Development of in vitro and in vivo preclinical models for small bowel NET
Po Hien Ear, PhD